Silence Therapeutics (SLN) logo

SLN earnings date, and what happened the last 4 times

Next report

Thu Nov 5

Quality Score today 12

Before the open, in 10 days. Expected: the company has not confirmed it.

SLN closed higher after 2 of its last 4 reports. On average it closed +5.5% the session after a report.

The moment SLN reports

  • Its figures, in plain words
  • How it moves after, beside its last four
  • Its Quality Score going in, and after
Get an alert when SLN reports, with its figures

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

What happened after SLN's last 4 reports

SLN's last 4 earnings reports
ReportedScore
going in
GapReaction
Aug 10, 20262026 · Before open10estimated+39.8%+29.1%
May 7, 20262026 · Before open5estimated-1.2%-5.6%
Mar 5, 20262026 · Before open-3estimated-6.6%-4.8%
Nov 6, 20252025 · Before open2estimated+0.2%+3.4%
  • Aug 10, 2026, before the open: that session SLN opened +39.8% and closed +29.1%, and five sessions on it stood +14.8%. Its Quality Score going in was 10 (Average), estimated.
  • May 7, 2026, before the open: that session SLN opened -1.2% and closed -5.6%, and five sessions on it stood -5.2%. Its Quality Score going in was 5 (Below Average), estimated.
  • Mar 5, 2026, before the open: that session SLN opened -6.6% and closed -4.8%, and five sessions on it stood +20.8%. Its Quality Score going in was -3 (Poor), estimated.
  • Nov 6, 2025, before the open: that session SLN opened +0.2% and closed +3.4%, and five sessions on it stood +7.8%. Its Quality Score going in was 2 (Below Average), estimated.

Across these 4 reports SLN opened higher after 2 of 4 and closed higher after 2 of 4; on average it opened +8.0%, closed +5.5%, and stood +9.6% five sessions on. Its Quality Score is 12 today, against 10 going into its Aug 10, 2026 report.

Gap: where the stock opened the session after the report. Reaction: where that session closed. Both against the close before the report. The largest of the 4: +29.1% after the Aug 10, 2026 report. A score marked estimated was worked out afterwards from that day's prices and filings; Breakaway has recorded every score live since Sep 9 2026.

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Pro members see SLN's reaction live as a report comes out, the release's figures, and an optional alert before it reports.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Questions about SLN's earnings

As of Oct 26, 2026: Silence Therapeutics (SLN): expected to report Thu Nov 5, before the open. SLN closed higher after 2 of its last 4 reports. Its Quality Score is 12 (Above Average). Scores as of 10:16 PM ET, 15 minutes behind.

When is SLN's next earnings date?

Expected to report Thu Nov 5, before the open, a date Breakaway expects from the company's usual timing; the company has not confirmed it. SLN closed higher after 2 of its last 4 reports. Past behavior, not a forecast.

Does SLN report before or after the market?

SLN is expected to report Thu Nov 5, before the open. Its last 4 reports came before the open.

How did SLN stock react to its last earnings report?

Aug 10, 2026, before the open: that session SLN opened +39.8% and closed +29.1%, and five sessions on it stood +14.8%.

Does SLN stock usually go up after earnings?

SLN closed higher after 2 of its last 4 reports. On average it closed +5.5% the session after a report, after opening +8.0%. Past behavior, not a forecast.

Silence Therapeutics' page has its Quality Score, its chart, and its insiders' trades. Everyone reporting beside it: next week's earnings.

Past behavior, not a forecast. The score is delayed at least 15 minutes; the reports' moves are as they closed.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs; recorded live since Sep 9 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.